Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil added to standard therapy for chronic heart failure
ChiCTR-TRC-12002250Phase 4Completed
- Sponsor
- Heart Center, First Affiliated Hospital of Xinjiang Medical University
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicorandil in chronic heart failure (CHF) (2 arms), sponsored by Heart Center, First Affiliated Hospital of Xinjiang Medical University. Primary endpoint: Six-minute walk test. Started Jun 2012; status: completed.
02
Drugs
nicorandil
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR-TRC-12002250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002250.